JP2007508273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508273A5 JP2007508273A5 JP2006530156A JP2006530156A JP2007508273A5 JP 2007508273 A5 JP2007508273 A5 JP 2007508273A5 JP 2006530156 A JP2006530156 A JP 2006530156A JP 2006530156 A JP2006530156 A JP 2006530156A JP 2007508273 A5 JP2007508273 A5 JP 2007508273A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- virus
- polypeptide
- spp
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323968.8A GB0323968D0 (en) | 2003-10-13 | 2003-10-13 | Immunogenic compositions |
| PCT/EP2004/011621 WO2005039630A2 (en) | 2003-10-13 | 2004-10-11 | Immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508273A JP2007508273A (ja) | 2007-04-05 |
| JP2007508273A5 true JP2007508273A5 (enExample) | 2007-07-19 |
Family
ID=29559207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530156A Pending JP2007508273A (ja) | 2003-10-13 | 2004-10-11 | 免疫原性組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070212328A1 (enExample) |
| EP (1) | EP1684802A2 (enExample) |
| JP (1) | JP2007508273A (enExample) |
| KR (1) | KR20060131749A (enExample) |
| CN (1) | CN1893974A (enExample) |
| AU (1) | AU2004283458A1 (enExample) |
| BR (1) | BRPI0415315A (enExample) |
| CA (1) | CA2541693A1 (enExample) |
| CO (1) | CO5700789A2 (enExample) |
| GB (1) | GB0323968D0 (enExample) |
| IL (1) | IL174542A0 (enExample) |
| IS (1) | IS8387A (enExample) |
| MA (1) | MA28106A1 (enExample) |
| NO (1) | NO20061911L (enExample) |
| RU (1) | RU2006111849A (enExample) |
| WO (1) | WO2005039630A2 (enExample) |
| ZA (1) | ZA200602948B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003259827B2 (en) * | 2002-08-12 | 2008-09-04 | Dynavax Technologies Corporation | Immunomodulatory compositions, methods of making, and methods of use thereof |
| WO2004091517A2 (en) * | 2003-04-15 | 2004-10-28 | Smithkline Beecham Corporation | Conjugates comprising human il-18 and substitution mutants thereof |
| CA2662609A1 (en) * | 2006-09-14 | 2008-03-20 | The Trustees Of The University Of Pennsylvania | Modulation of regulatory t cells by human il-18 |
| SE532249C2 (sv) * | 2006-11-13 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering |
| WO2008142133A1 (en) | 2007-05-24 | 2008-11-27 | Glaxosmithkline Biologicals S.A | Lyophilised antigen composition |
| WO2009108235A2 (en) * | 2007-12-07 | 2009-09-03 | Tekmira Pharmaceuticals Corporation | Compositions and methods for modulating immune responses to nucleic acids |
| GB0810869D0 (en) * | 2008-06-13 | 2008-07-23 | Isis Innovation | Vaccine adjuvant composition |
| TWI351288B (en) * | 2008-07-04 | 2011-11-01 | Univ Nat Pingtung Sci & Tech | Cpg dna adjuvant in avian vaccines |
| WO2010064146A2 (en) | 2008-12-02 | 2010-06-10 | Chiralgen, Ltd. | Method for the synthesis of phosphorus atom modified nucleic acids |
| ES2399218T3 (es) * | 2008-12-23 | 2013-03-26 | Intervet International Bv | Saponinas inmunoestimulantes para usar en terapia de destrucción tumoral in situ |
| EP2202298A1 (en) | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| PL2444103T3 (pl) * | 2009-06-19 | 2018-05-30 | Eyegene Inc. | Szczepionka przeciwko rakowi szyjki macicy |
| CA2767253A1 (en) | 2009-07-06 | 2011-01-13 | Ontorii, Inc. | Novel nucleic acid prodrugs and methods of use thereof |
| CN101814489A (zh) * | 2010-03-02 | 2010-08-25 | 晶科电子（广州）有限公司 | 带有功能芯片的发光二极管封装结构及其封装方法 |
| EP2399572A1 (en) | 2010-06-22 | 2011-12-28 | Sandoz AG | Long-term storage of non-glycosylated recombinant human G-CSF |
| CN103796657B (zh) | 2011-07-19 | 2017-07-11 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
| US20140105970A1 (en) * | 2011-12-01 | 2014-04-17 | Flow Pharma, Inc. | Adjuvant and antigen particle formulation |
| WO2013082503A1 (en) * | 2011-12-01 | 2013-06-06 | Flow Pharma, Inc. | Peptide particle formulation |
| JP6453212B2 (ja) | 2012-07-13 | 2019-01-16 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | キラル制御 |
| WO2014010250A1 (en) | 2012-07-13 | 2014-01-16 | Chiralgen, Ltd. | Asymmetric auxiliary group |
| CA2879066C (en) * | 2012-07-13 | 2019-08-13 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
| JPWO2015108046A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤 |
| JPWO2015108048A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
| WO2015108047A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| KR20230152178A (ko) | 2014-01-16 | 2023-11-02 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
| CN116327912A (zh) * | 2021-12-23 | 2023-06-27 | 上海泽润生物科技有限公司 | 带状疱疹疫苗组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE292980T1 (de) * | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| US6291430B1 (en) * | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| ES2284247T3 (es) * | 1998-04-03 | 2007-11-01 | University Of Iowa Research Foundation | Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos. |
| WO1999056775A1 (en) * | 1998-05-07 | 1999-11-11 | Akzo Nobel N.V. | Use of interleukin-18 as vaccine adjuvant |
| US6562798B1 (en) * | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| EP1187629B1 (en) * | 1999-04-19 | 2004-09-22 | GlaxoSmithKline Biologicals S.A. | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| AU2001245414A1 (en) * | 2000-03-10 | 2001-09-24 | The Board Of Trustees Of Leland Stanford Junior University | Treatment of allergies |
-
2003
- 2003-10-13 GB GBGB0323968.8A patent/GB0323968D0/en not_active Ceased
-
2004
- 2004-10-11 JP JP2006530156A patent/JP2007508273A/ja active Pending
- 2004-10-11 BR BRPI0415315-4A patent/BRPI0415315A/pt not_active Application Discontinuation
- 2004-10-11 CA CA002541693A patent/CA2541693A1/en not_active Abandoned
- 2004-10-11 RU RU2006111849/14A patent/RU2006111849A/ru not_active Application Discontinuation
- 2004-10-11 WO PCT/EP2004/011621 patent/WO2005039630A2/en not_active Ceased
- 2004-10-11 EP EP04790466A patent/EP1684802A2/en not_active Withdrawn
- 2004-10-11 KR KR1020067009353A patent/KR20060131749A/ko not_active Withdrawn
- 2004-10-11 AU AU2004283458A patent/AU2004283458A1/en not_active Abandoned
- 2004-10-11 US US10/575,836 patent/US20070212328A1/en not_active Abandoned
- 2004-10-11 CN CNA2004800372174A patent/CN1893974A/zh active Pending
-
2006
- 2006-03-23 IL IL174542A patent/IL174542A0/en unknown
- 2006-03-30 IS IS8387A patent/IS8387A/is unknown
- 2006-04-07 CO CO06034534A patent/CO5700789A2/es not_active Application Discontinuation
- 2006-04-11 ZA ZA200602948A patent/ZA200602948B/xx unknown
- 2006-04-25 MA MA28960A patent/MA28106A1/fr unknown
- 2006-04-28 NO NO20061911A patent/NO20061911L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007508273A5 (enExample) | ||
| RU2006111849A (ru) | Иммуногенные композиции | |
| JP2007508272A5 (enExample) | ||
| RU2006111847A (ru) | Вакцинные композиции, содержащие интерлейкин 18 и сапониновую адъювантную систему | |
| Lacaille-Dubois | Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review | |
| O'Hagan et al. | Recent developments in adjuvants for vaccines against infectious diseases | |
| Lahiri et al. | Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond | |
| AU764969B2 (en) | Vaccines | |
| CN100346829C (zh) | 包含免疫刺激性寡核苷酸和母育酚的佐剂组合物 | |
| JP2014520807A5 (enExample) | ||
| WO1999052549A1 (en) | Adjuvant compositions | |
| AU2002221689A1 (en) | Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol | |
| JP2006506441A5 (enExample) | ||
| JP5307859B2 (ja) | ワクチン | |
| CN1980691A (zh) | 用于癌症免疫疗法的基于mage－3和ny－eso－1的多价疫苗 | |
| US20120020993A1 (en) | Vaccine | |
| Arora et al. | Oral mucosal immunization: Recent advancement and future prospects | |
| Acevedo et al. | Adjuvantes: Un componente esencial de las vacunas de Neisseria | |
| Acevedo et al. | Adjuvants: an essential component of neisseria vaccines | |
| Davis et al. | Novel Strategies Using DNA for the Induction of Mucosal Immunity | |
| HK1118481A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| HK1151231A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| HK1079088A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |